Technical420 Site Search

Last week, Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) released a corporate update and we are favorable on how the story has advanced so far this year. We recently identified Australis as an emerging US cannabis company that is executing on a capital light expansion strategy. Through the (part) ownership…

Earlier this week, Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) reported a major milestone and formed an agreement with Arizona's largest cannabis wholesaler, Copperstate Farms Management, through its majority owned subsidiary ALPS. We are bullish on the relationship with Copperstate Farms and consider it to be a potential major revenue…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that the Company, through its majority owned subsidiary ALPS, has entered into an agreement with Copperstate Farms Management, LLC, Arizona's largest cannabis wholesaler. The Project Copperstate Farms currently operates a 40-acre, ~1.7 million square-foot greenhouse in Snowflake, Arizona , cultivating medical…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced it has appointed Dr. Jason Dyck as its new Chief Science Officer, and Chairman of its Scientific Advisory Board. (SAB). The appointment is in line with the Company's strategy to leverage the roots of its management team in medical cannabis, and…

With New York on the verge of legalizing recreational cannabis, we have seen an influx in questions concerning the US cannabis market. The US cannabis industry was the biggest winner of the 2020 general election and has been receiving much more mainstream media coverage since then. The combination of 8…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that, further to the Company's press releases of January 5, 2021 , and March 12, 2021 , it has completed the first stage of the transaction to acquire Green Therapeutics LLC. The transaction is being completed in two parts, the first,…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced that, further to the Company's press release of January 5, 2021 , AUSA has entered into a definitive agreement on March 11, 2021 with, among others, Green Therapeutics LLC ("GT") and the holders of the issued and…

Although we are still only in the first quarter of 2021, the number of reported acquisitions in the cannabis industry has already significantly surpassed the activity we saw in the first half of 2020. During the last month, we conducted significant due diligence on several leading cannabis companies that announced…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) ("AUSA" or the "Company") today announced that, further to its press releases dated January 5, 2021 and February 24, 2021 , the Company has completed the acquisition of a 51% ownership interest in 2750176 Ontario Inc. ("ALPS") for initial consideration of $10,000,000 in shares…

Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) today announced that the Company has entered into a binding terms sheet concerning a joint venture (JV) partnership with 3 Rivers Biotech Inc. ("3 Rivers"), a leading agricultural technology company specialised in commercial scale micropropagation, or plant tissue culture (PTC), for cannabis, hemp…